Atsena Therapeutics Announces Positive 12-Month Safety and Efficacy Data From Ongoing Phase I/II Clinical Trial To Treat Leber Congenital Amaurosis
Atsena Therapeutics announced positive results in their 12-month safety and efficacy data from the ongoing Phase I/II trial of ATSN-101, the company’s investigational gene therapy for the treatment of GUCY2D-associated Leber congenital amaurosis (LCA1). At 12 months post-treatment, ATSN-101 has conferred clinically meaningful improvements in vision at the highest dose with no serious treatment-emergent adverse events.
Computer Science Student Finds Inspiration at the Forefront of Innovation
Computer science student Niranjan expanded his horizons by exploring a world of innovation.
The University of Florida, Concept Companies, and Trimark Properties Join Forces To Make Gainesville’s Innovation District a Major Economic Hub
The UF Board of Trustees is partnering with Concept Companies and Trimark Properties to expand Gainesville's Innovation District with 13 acres of land in the development pipeline.
The plan aims to boost the Innovation District's presence as a place for new ideas and thriving new companies. From AI to BioTech, these new spaces will allow innovation to thrive in Gainesville and across the UF campus.
Tech Tuesday – Adam Veige
In this week's Tech Tuesday for WCJB TV20, UF Innovate's Melanie Morón interviews Adam Veige, professor in the UF Department of Chemistry and winner of an Invention of the Year award at StandingInnOvation 2023. He explains his invention, a cyclic version of polypropylene, which he aims to commercialize.
University of Florida Ranks Among Top 25 Universities With $1.085 Billion in 2022 Research Expenditures
The University of Florida’s $1.085 billion in research expenditures in fiscal year 2022 placed it 25th among all U.S. universities, up from 27th in 2021, in a new national ranking of R&D spending by the National Science Foundation. UF was 15th among public universities, up from 16th.
Combination of Two Common Compounds Improves COVID Survival in Mice, UF Researchers Find
Researchers at the University of Florida have discovered the combination of Lactoferrin, a protein found in cow and human milk, and diphenhydramine, an antihistamine used for allergy symptoms, increased resilience of mice towards the virus that causes COVID-19.
UF Brain Institute Receives $1 Million for Stroke Research Project
The University of Florida’s McKnight Brain Institute received $1 million to support a stroke research project. The funds are part of UF President Ben Sasse’s $10.9 million strategic funding initiative aimed at boosting the university's position as a leader in critical research.
The funds will be used to launch a new project that utilizes AI to improve stroke treatments.
Tech Tuesday – Cherie Stabler
In this week's Tech Tuesday for WCJB TV20, UF Innovate's Melanie Morón interviews Cherie Stabler, researcher and professor in the UF Department of Biomedical Engineering, who is conducting research on a possible cure for type 1 diabetes.
President’s Office Announces $10.9 Million for Third Round of Strategic Funding Awardees
UF President Ben Sasse announced a third round of strategic funding, which will see $10.9 million spread across 10 new projects aimed at solidifying UF's standing as a national research leader.
